Leiherer A[au] - Search Results

Year	Number of Results
2003	1
2008	1
2009	2
2011	1
2012	2
2013	2
2014	6
2015	6
2016	5
2017	5
2018	6
2019	13
2020	7
2021	7
2022	12
2023	2

1

Volatilomic Signatures of AGS and SNU-1 Gastric Cancer Cell Lines.

Ślefarska-Wolak D, Heinzle C, Leiherer A, Ager C, Muendlein A, Mezmale L, Leja M, Corvalan AH, Drexel H, Królicka A, Shani G, Mayhew CA, Haick H, Mochalski P. Ślefarska-Wolak D, et al. Among authors: leiherer a. Molecules. 2022 Jun 22;27(13):4012. doi: 10.3390/molecules27134012. Molecules. 2022. PMID: 35807254 Free PMC article.

2

Serotonin is elevated in risk-genotype carriers of TCF7L2 - rs7903146.

Leiherer A, Muendlein A, Saely CH, Fraunberger P, Drexel H. Leiherer A, et al. Sci Rep. 2019 Sep 6;9(1):12863. doi: 10.1038/s41598-019-49347-y. Sci Rep. 2019. PMID: 31492908 Free PMC article.

3

Phytochemicals and their impact on adipose tissue inflammation and diabetes.

Leiherer A, Mündlein A, Drexel H. Leiherer A, et al. Vascul Pharmacol. 2013 Jan;58(1-2):3-20. doi: 10.1016/j.vph.2012.09.002. Epub 2012 Sep 12. Vascul Pharmacol. 2013. PMID: 22982056 Review.

4

Comparison of recent ceramide-based coronary risk prediction scores in cardiovascular disease patients.

Leiherer A, Mündlein A, Laaksonen R, Lääperi M, Jylhä A, Fraunberger P, Drexel H. Leiherer A, et al. Eur J Prev Cardiol. 2022 May 6;29(6):947-956. doi: 10.1093/eurjpc/zwab112. Eur J Prev Cardiol. 2022. PMID: 34417607

5

Serum glypican-4 is a marker of future vascular risk and mortality in coronary angiography patients.

Muendlein A, Brandtner EM, Leiherer A, Geiger K, Heinzle C, Gaenger S, Fraunberger P, Mader A, Saely CH, Drexel H. Muendlein A, et al. Among authors: leiherer a. Atherosclerosis. 2022 Mar;345:33-38. doi: 10.1016/j.atherosclerosis.2022.02.015. Epub 2022 Feb 13. Atherosclerosis. 2022. PMID: 35202959

6

Evaluation of the association of serum glypican-4 with prevalent and future kidney function.

Muendlein A, Brandtner EM, Leiherer A, Geiger K, Heinzle C, Gaenger S, Fraunberger P, Haider D, Saely CH, Drexel H. Muendlein A, et al. Among authors: leiherer a. Sci Rep. 2022 Jun 17;12(1):10168. doi: 10.1038/s41598-022-14306-7. Sci Rep. 2022. PMID: 35715556 Free PMC article.

7

Gamma-glutamyl-transferase is associated with incident hip fractures in women and men ≥ 50 years: a large population-based cohort study.

Brozek W, Ulmer H, Pompella A, Nagel G, Leiherer A, Preyer O, Concin H, Zitt E. Brozek W, et al. Among authors: leiherer a. Osteoporos Int. 2022 Jun;33(6):1295-1307. doi: 10.1007/s00198-022-06307-z. Epub 2022 Jan 20. Osteoporos Int. 2022. PMID: 35059776

8

Embedding permanent watermarks in synthetic genes.

Liss M, Daubert D, Brunner K, Kliche K, Hammes U, Leiherer A, Wagner R. Liss M, et al. Among authors: leiherer a. PLoS One. 2012;7(8):e42465. doi: 10.1371/journal.pone.0042465. Epub 2012 Aug 8. PLoS One. 2012. PMID: 22905136 Free PMC article.

9

Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients.

Muendlein A, Severgnini L, Decker T, Heinzle C, Leiherer A, Geiger K, Drexel H, Winder T, Reimann P, Mayer F, Nonnenbroich C, Dechow T. Muendlein A, et al. Among authors: leiherer a. Front Oncol. 2022 Oct 24;12:1045995. doi: 10.3389/fonc.2022.1045995. eCollection 2022. Front Oncol. 2022. PMID: 36353562 Free PMC article.

10

The value of uromodulin as a new serum marker to predict decline in renal function.

Leiherer A, Muendlein A, Saely CH, Brandtner EM, Geiger K, Fraunberger P, Drexel H. Leiherer A, et al. J Hypertens. 2018 Jan;36(1):110-118. doi: 10.1097/HJH.0000000000001527. J Hypertens. 2018. PMID: 28858977

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results